
Jun 13, 2026
Abridge Secures Strategic Investment From Eli Lilly, Expands AI Platform Into Payer and Research Workflows
Abridge has recently announced a strategic investment from Eli Lilly, marking a significant expansion of its AI platform into payer and research workflows.Healthcare AI company Abridge is enhancing its capabilities by integrating its platform with payer, reimbursement, clinical decision support, and research workflows. The announcement was made by CEO Dr. Shiv Rao during an event in New York City, although financial specifics of the investment were not disclosed. This expansion allows Abridge to









